Association of Nadir PSA >0.5ng/Ml after Dose Escalated External Beam Radiation With Prostate Cancer-Specific Endpoints

被引：0
|
作者：
Sheth, N. [1 ,2 ]
Osborn, V. W. [1 ,2 ]
Lee, A. [1 ,2 ]
Schwartz, D. [2 ]
Schreiber, D. [2 ]
机构：
[1] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
[2] Vet Affairs NY Harbor Healthcare Syst, Brooklyn, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.1235
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2632
引用
收藏
页码：E264 / E265
页数：2
相关论文
共 50 条
  • [41] Prostate-specific antigen (PSA) nadir and experience of PSA bounce after low-dose-rate brachytherapy for prostate cancer predicts clinical failure
    Nakai, Yasushi
    Tanaka, Nobumichi
    Asakawa, Isao
    Onishi, Kenta
    Miyake, Makito
    Yamaki, Kaori
    Fujimoto, Kiyohide
    BRACHYTHERAPY, 2024, 23 (06) : 727 - 736
  • [42] PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: A multi-institutional analysis
    Ray, ME
    Thames, HD
    Levy, LB
    Horwitz, EM
    Kupelian, PA
    Martinez, AA
    Michalski, JM
    Pisansky, TM
    Shipley, WU
    Zelefsky, MJ
    Zietman, AL
    Kuban, DA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (04): : 1140 - 1150
  • [43] Prostate specific bounce phenomenon after external beam radiation for clinically localized prostate cancer
    Schwarz, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 (03) : 181 - 182
  • [44] 18-YEAR PROSTATE CANCER-SPECIFIC MORTALITY AFTER PROSTATECTOMY, BRACHYTHERAPY, EXTERNAL BEAM RADIATION THERAPY, HORMONAL THERAPY, OR MONITORING FOR LOCALIZED PROSTATE CANCER
    Herlemann, Annika
    Cowan, Janet E.
    Washington, Samuel L., III
    Broering, Jeanette M.
    Carroll, Peter R.
    Cooperberg, Matthew R.
    JOURNAL OF UROLOGY, 2019, 201 (04): : E737 - E738
  • [45] Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer
    Herlemann, Annika
    Cowan, Janet E.
    Washington, Samuel L.
    Wong, Anthony C.
    Broering, Jeanette M.
    Carroll, Peter R.
    Cooperberg, Matthew R.
    EUROPEAN UROLOGY, 2024, 85 (06) : 565 - 573
  • [46] 18-year prostate cancer-specific mortality after prostatectomy, brachytherapy, external beam radiation therapy, hormonal therapy, or monitoring for localized prostate cancer
    Herlemann, Annika
    Cowan, Janet E.
    Washington, Samuel L.
    Wong, Anthony C.
    Broering, Jenny M.
    Carroll, Peter R.
    Cooperberg, Matthew R.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [47] Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer: The relationship between nadir level and disease-free survival
    Lee, WR
    Hanlon, AL
    Hanks, GE
    JOURNAL OF UROLOGY, 1996, 156 (02): : 450 - 453
  • [48] A Matched Comparison of Patients Treated With Standard Dose External Beam Radiation Versus Dose-Escalated, Adaptive, Image Guided External Beam Radiation for Favorable Intermediate-Risk Prostate Cancer
    Ye, H.
    Blas, K. G.
    Yan, D.
    Brabbins, D. S.
    Gustafson, G. S.
    Marvin, K.
    Wallace, M.
    Krauss, D. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E271 - E271
  • [49] The prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer
    Rosser, CJ
    Kuban, DA
    Levy, LB
    Chichakli, R
    Pollack, A
    Lee, AK
    Pisters, LL
    JOURNAL OF UROLOGY, 2002, 168 (05): : 2001 - 2005
  • [50] Re: Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer
    Montorsi, Francesco
    Longoni, Mattia
    Briganti, Alberto
    Gandaglia, Giorgio
    EUROPEAN UROLOGY, 2025, 87 (01) : 93 - 94
12345